Expression of TIM-3 on Lymphocytes in Sepsis

The Efficacy and Safety of Ta1 for Sepsis

NCT02867267 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis

NCT02883595 ·Status: COMPLETED ·Phase: PHASE4

Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients

NCT05911711 ·Status: UNKNOWN

Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism

NCT02361970 ·Status: COMPLETED

TRIM25 in Septic Patients

NCT07320638 ·Status: ENROLLING_BY_INVITATION

Dissecting How Peripheral Lymphocytes Are Lost During Sepsis

NCT03289312 ·Status: UNKNOWN

The Changes of CD4+T Lymphocyte Subsets in Septic Patients

NCT01494389 ·Status: UNKNOWN

The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney Injuries

NCT01333657 ·Status: COMPLETED

Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient

NCT02881710 ·Status: COMPLETED

Efficacy of Thymosin alpha1 for Severe Sepsis

NCT00711620 ·Status: COMPLETED ·Phase: NA

Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms

NCT03379896 ·Status: UNKNOWN

Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis

NCT05640037 ·Status: COMPLETED

TREM-1 Gene Polymorphisms

NCT01490424 ·Status: COMPLETED

Myeloid-derived Suppressor Cells in Sepsis

NCT03540797 ·Status: UNKNOWN

MiRNAs Evaluating Lymphocyte Proliferation and Apoptosis as Well as Prognosis of Sepsis

NCT02756559 ·Status: UNKNOWN

Effect of Immunophenotype on Prognosis of Sepsis

NCT05602584 ·Status: UNKNOWN

Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis

NCT02887274 ·Status: UNKNOWN

The Th9/IL-9 and Early Enteral Nutrition in Sepsis

NCT03791866 ·Status: UNKNOWN ·Phase: NA

Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis

NCT03842371 ·Status: UNKNOWN

The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis

NCT03340649 ·Status: UNKNOWN

PD-1/PD-L1 Pathway Study on Septic Patients

NCT01161745 ·Status: COMPLETED

Immune Function Monitoring and Immunotherapy in Sepsis

NCT04903405 ·Status: UNKNOWN

Immune Homeostasis in Sepsis and Septic Shock

NCT04448951 ·Status: RECRUITING

Biomarkers for the Early Identification of Sepsis in the Emergency Department

NCT02707718 ·Status: COMPLETED

Droplet Digital PCR Combines With Transcriptome Analysis in Early Warning of Sepsis in the Emergency Department

NCT06028178 ·Status: NOT_YET_RECRUITING